Wednesday, December 18, 2019 9:57:57 AM
It won't be until Q2 that results get really hard to ignore. If you look at the 10k their orders in backlog right now are 5.8 million. They do a really nice job of guiding on their delivery schedules and its likely that 5.8 is in the ballpark of where they will be. There may be a bit of upside to that around the DLA order as well as normal variance up and down, but revenues are going to likely be in the 6 million range.
They did mention their "distractions" are behind them which I am interpreting to mean their margin issues. That leaves me figuring .06-.07 is a good guess for next quarter.
Where it really gets interesting in Q2. They already have 6.8 in the backlog for Q2 delivery. That number almost always increases as the quarter approaches (with 1 recent exception). It wouldn't surprise me to see revenue in Q2 of 7.5 million and EPS as high as .15/share. That isn't going to be ignorable, and I think it would get you to 5 dollars. Then G&H revenue should hit in the back half of 2020.
Recent OPXS News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 08:46:32 PM
- LifeVantage Appoints Dayton Judd to the Board of Directors • GlobeNewswire Inc. • 02/15/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 02:30:11 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/22/2024 09:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 09:30:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 09:22:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 11:04:26 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM